{"name":"Shanghai Zhangjiang Biotechnology Limited Company","slug":"shanghai-zhangjiang-biotechnology-limited-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CMAB009 plus Irinotecan","genericName":"CMAB009 plus Irinotecan","slug":"cmab009-plus-irinotecan","indication":"Metastatic colorectal cancer","status":"phase_2"}]}],"pipeline":[{"name":"CMAB009 plus Irinotecan","genericName":"CMAB009 plus Irinotecan","slug":"cmab009-plus-irinotecan","phase":"phase_2","mechanism":"CMAB009 is a PD-1 inhibitor, and Irinotecan is a topoisomerase I inhibitor.","indications":["Metastatic colorectal cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOaHhMTTd1UFpMSjNFVFQ3WWk4YXcwSHJTUDdVcWtBS3VzR1U1TThTcmlXbEpBVWU1UHIyOGk5eEppUXJmX1RpWExjb09MMU8xSjVYZGtvWE1Ba0NQZGFRUktkVS1LdXBuVFFBTG1rSmtqUzJ1d1FDdjNRM05nT1BqUVFXVGdMWHBBYWtDZWhsUENZSk5CQklNYmxpR25vU3d4VkF2NmNiS3FMUUxlcXl3OUtraFROR2lZZ0E1X2lRYXRVWHluaUtjMVlRMnZMUXNSNFZ6UURrUHgwVDlOSXNxdi1nU1FxWDQ?oc=5","date":"2026-04-02","type":"pipeline","source":"marketscreener.com","summary":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes to structured deposit product under Bank of China - marketscreener.com","headline":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes to structured deposit product under Bank of China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOTmZTWlhpSWR2bklHaVB4U1BMLW4yMGhodDZnLUpRTnJ1ajVfQjd4X0NSYVR3enRiZHdlV1dlSExCeGt2MUdtWGpnbzlWMXZzcVZuRFN3UndsQXNXT2k1N0FvSmwtbkNnS3ItZ25nWU9HSU51VWM3a3EtOFoxZ0xoRVhSZ3pwaEN1MFBlU0JaTm4xcEJoSlpIMnJDV1FkUWdFUk9oOFdiNGFNR2NrcGxsUkRUQ29YM2VLbmRCQldyb0p3THlDNmhn?oc=5","date":"2026-03-30","type":"pipeline","source":"TipRanks","summary":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Sets Slate for Ninth-Term Board - TipRanks","headline":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Sets Slate for Ninth-Term Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxObVhWeG5jWnhKYVcyOW9UVUZKS2J4UmU3Qi13TnFGajQ1NzZMYW1QbWlqQTZFUjIyODROeGFGc1pNWGk3UEV4NHdSMUpCcjM1b2lwdEk4NFNNZkpJa0tHUW1GVEVIN296b2V6cXRkSFMtUXBZWGZSM2JLY2IxWFo4Slo4cFVzemJuMGp4MDNIRHZyME5vOE5QYURqTDM0ajYzSzUwM081SDRkOHhyTEdObGQ5b05LZkc1bEdVMXN1VmJncHZkeTE0U2RPX3ZjWHdWT1QwbllpMERDTjkyQUQzLWpKRVBXQQ?oc=5","date":"2026-03-30","type":"pipeline","source":"marketscreener.com","summary":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Omits to Recommend Final Dividend for the Year Ended 31 December 2025 - marketscreener.com","headline":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Omits to Recommend Final Dividend for the Year Ended 31 December 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPQ1BjWEg2TlkzQVg2NDlrSFdmMGhtWExpaHltcmFibUFnZDFCbV9xM1Jxd1NMdm05T3lyb1Z2UjZtc0RGWTQ5YUNQSmtfLUszTTEtZmNpM2ZXU1VpdGV5Mk4zeHZjR2pIQVVEczZXTmlCTjZDSHI2TmJicmtuNndsd2VSRzNYZGJGZF90TlFYeWtGcVZiYTgxUmhUNVo0VUJpbXlzcE1vcXBIUlJNVjU3UXZjTzVwX0lhZ3k0a3BvSlNJcXBfV1ZN?oc=5","date":"2026-03-30","type":"earnings","source":"TipRanks","summary":"Shanghai Fudan-Zhangjiang Swings to 2025 Net Loss as Revenue Slide Continues - TipRanks","headline":"Shanghai Fudan-Zhangjiang Swings to 2025 Net Loss as Revenue Slide Continues","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQVFQ0YlpTSHFJdGdjaUJvRENzX0w1R1ViMUVCUUN0bzBtQnFHN2V6S1dCV0RmM2dJS3RkQ2cyNUl1YXA4VkFPbFhCMTlpWjNJeTR0cnIwUW9aQTltVE10dnZVX21NX2pWR0UzMXdvYjVyX1ZvR29mOVIxQXZIRW16RmJFX0RWaVdvaEIydG9RcVVFQy1SaHpXRWwxMFo0am9ieVBtVE11T3JZYXRobFVsOHdyQ0I2WW9DRGVZXy1n?oc=5","date":"2026-02-20","type":"pipeline","source":"BioWorld News","summary":"Shanghai Fudan Zhangjiang Biopharmaceutical synthesizes new compounds for cancer - BioWorld News","headline":"Shanghai Fudan Zhangjiang Biopharmaceutical synthesizes new compounds for cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNdlhGY0UwZTN1UXVGQzQtZmx1TUpCWkZmcVhHRzZVcWpRcUhrYUVLMjVYZThrc1UyZTcyXzZscFlOV190Qk42eGdEaFRRU3g5bHVvSkxHbmdzQzZJT0RLb1pTbGdIall5ZlRudEdTb0ZtaERDUUo2bDJfb2ZRQjBNcGFKcEM0UEZTdnh4Vw?oc=5","date":"2026-02-19","type":"pipeline","source":"TargetJobs","summary":"Paid Internship in China: Biology, Chemical & Medicine - TargetJobs","headline":"Paid Internship in China: Biology, Chemical & Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxONTByZzhST21vY1RHTUR3V1lPSFVlbHV1R1Z3bTdETGVJNWpHYm94bDhjMGhCWGZQNEU1YVZVeXkxMk5mbWJ1STU2OTVQd3JJWl9yeGNnMEJMSmRlTlpHUDVBN0U4U3RocERDVVB1aDVjVGRmcFh5R01IMmJXM25tNzdtaWdtUWtRenFHOEhtNC1GTVNzUFVtVTB5dzh0WHpRUWJwZDE3S1dYanU0NVV6YlNidzBQVVUtWW13?oc=5","date":"2025-12-05","type":"pipeline","source":"Fierce Biotech","summary":"Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability - Fierce Biotech","headline":"Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNczVULWduQk0xZkowWThRZ0NNQnVvVHpFMVVMX0Z1SG1SRTA5dUFiSnR1RkxLVkxWNHpjZHBiODM2dG9QUFpjUXE4T2VrcHFjYnFncjNzTGxIZ2Y4aTJHVVM3aHdXR1QwVUJoREVOMExNRF9ic2plRC1UNzRfZHhjak1xdXRwUTR2UWVQbTRISFJwOFF3RW5QaXROeXNBU2RuZDFQR1E0RDJKbkZoQXMyaklrSzJ0QQ?oc=5","date":"2025-12-05","type":"pipeline","source":"AsiaTechDaily","summary":"Why Pfizer’s Venture Arm Is Backing a Stealthy Shanghai Biotech With US$100M to Rethink R&D - AsiaTechDaily","headline":"Why Pfizer’s Venture Arm Is Backing a Stealthy Shanghai Biotech With US$100M to Rethink R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFAyMnRkdkdwUWJEX2d2Q1I0SEU4Sl9wQnVHTTlJRlJRYm9lbzFKQXhzQUk5X3ZNZDFiRUpfV0hpd2wxRGNXd2dkQzlCcHFNX2x6MEpzbVRENzR5c0lINFpz?oc=5","date":"2025-10-16","type":"pipeline","source":"nature.com","summary":"A new kind of gateway to China’s biomedical boom - nature.com","headline":"A new kind of gateway to China’s biomedical boom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbzktb0ZpdUxHb0NIMGN5SjFBWG4zTjRCNmdqbHh4ZndyMjRfNHR6Yk1HNXpBVF93d1BlbzBNNGJfSXNNbnh4cGlxbFFiRmpwMmV4Vkd3WHJycDhfM1ZEZE1PcGVBb1htTVM0OW56cFBlZmVXV3FnZjdWcWtqZXV6aEY4RTFqODFNbUFfNVlOeW9kUm5BQUVhXzhudktUOWcxdUdWVlZtLVA?oc=5","date":"2025-08-06","type":"pipeline","source":"BioSpace","summary":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive - BioSpace","headline":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOalJtR2w0aVlVUFlGNlo5bEhmT1RxTmRmcm1FV1l0Z0dCQkVrSVN2aWo3dE1ERTBkR00zbzEwWUtGcjFiM2ZTc3NXeHBsbWZEYlU1Qk9QVXpvT21TMy10NlFiWnhXaTh5NXljeVJvalBmMkNBQXpfZzFUWHNJak1FLXlLZHptaGF2M2plZXQ3NjV3cjZLbmVhM3o1Q01CbXRiZFZQTm83Qlcyam93RnBJOFV4ZG9RU3cwZnJZTUhLejdNakZGbFZN?oc=5","date":"2024-10-01","type":"pipeline","source":"PR Newswire","summary":"PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight - PR Newswire","headline":"PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOUEFFZHpUWm1UWkQwWnlWekpSR212aTB3Q2JldGFXMFh5cnlZT1FPTDNHckR4QWxfMGtWeWdzeWJjTG5DWFRQS1RIUUYzcDZTNk9pa3pUUmZBU2Z5Yng2bTlwWHZoaTNxRUYwTXBHNEdhbjlKVzhwSFc2T2ZmODZGOGtZVk9QaXNkeXgtNTFjX2RrRm9seXlsLThEZ1NfeW1SYTBSeVlLMDZEVWRiWkRjNFZrVnIzdE5QcjdCbDQ3X24?oc=5","date":"2024-09-26","type":"pipeline","source":"Bayer","summary":"Bayer Co.Lab Shanghai opens as part of global expansion of life science incubator network - Bayer","headline":"Bayer Co.Lab Shanghai opens as part of global expansion of life science incubator network","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}